![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Tumor-associated macrophages (TAMs) are crucial for non-small cell lung cancer (NSCLC) development.
Objective: In this study, polylactic acid-co-glycolic acid (PLGA)-polyethylenimine (PEI) nanobubbles (NBs) carrying STAT6 siRNA were prepared and combined with ultrasound-mediated nanobubbles destruction (UMND) to silence the STAT6 gene, ultimately repolarizing TAMs from the M2 to the M1 phenotype, treating NSCLC in vitro.
Methods: PLGA-PEI NBs-siRNA were prepared and characterised, and their respective ultrasound imaging, biological stabilities and cytotoxicities were detected. Transfection efficiency was evaluated by fluorescence microscopy and flow cytometry. Repolarization of THP-1-derived M2-like macrophages was determined by qPCR and flow cytometry. NSCLC cells (A549) were co-cultured with transfected M2-like macrophages or their associated conditioned medium (CM). Western blotting was used to detect STAT6 gene silencing in M2-like macrophages and markers of epithelial and mesenchymal in A549 cells. The proliferation of A549 cells was detected using CCK-8 and cell colony formation assays. Transwell assays were used to detect the migration and invasion of A549 cells.
Results: PLGA-PEI NBs-siRNA had an average size of 223.13 ± 0.92 nm and a zeta potential of about -5.59 ± 0.97 mV. PLGA-PEI NBs showed excellent ultrasonic imaging capability in addition to biological stability to protect siRNA from degradation. UMND enhanced PLGA-PEI NBs-STAT6 siRNA transfection in M2-like macrophages, which made M2-like macrophages repolarize to M1-like macrophages and prevented proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) in A549 cells.
Conclusion: UMND enhanced PLGA-PEI NBs-STAT6 siRNA to repolarize TAMs from the M2 to the M1 phenotype, thus treating NSCLC. These findings provide a promising therapeutic approach for enhancing NSCLC immunotherapy.
Keywords: Tumor-associated macrophages, non-small cell lung cancer, STAT6 siRNA, ultrasound-mediated nanobubbles destruction, immunotherapy, M1 Phenotypes.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[http://dx.doi.org/10.1097/CM9.0000000000002108] [PMID: 35143424]
[http://dx.doi.org/10.1016/S0140-6736(19)32795-3] [PMID: 31777378]
[http://dx.doi.org/10.1016/j.cmet.2016.09.008] [PMID: 27773694]
[http://dx.doi.org/10.1186/s40164-021-00252-z] [PMID: 34965886]
[http://dx.doi.org/10.1186/s12967-020-02618-z] [PMID: 33228719]
[http://dx.doi.org/10.3390/molecules24010009] [PMID: 30577495]
[http://dx.doi.org/10.1016/j.cell.2014.04.016] [PMID: 24792964]
[http://dx.doi.org/10.1021/acscentsci.9b01235] [PMID: 32724855]
[http://dx.doi.org/10.1016/j.canlet.2016.11.029] [PMID: 27913199]
[http://dx.doi.org/10.3389/fimmu.2019.02638] [PMID: 31798581]
[http://dx.doi.org/10.1016/j.mam.2022.101148] [PMID: 36257857]
[http://dx.doi.org/10.1111/bph.15972] [PMID: 36250252]
[http://dx.doi.org/10.3390/pharmaceutics14030480] [PMID: 35335857]
[http://dx.doi.org/10.3390/cancers13143383] [PMID: 34298600]
[http://dx.doi.org/10.1016/j.jconrel.2022.06.054] [PMID: 35780954]
[http://dx.doi.org/10.1016/j.msec.2017.12.036] [PMID: 30184728]
[http://dx.doi.org/10.1080/10717544.2021.1938756] [PMID: 34184949]
[http://dx.doi.org/10.1016/j.ijpharm.2015.10.037] [PMID: 26475970]
[http://dx.doi.org/10.1016/j.carbpol.2019.115128] [PMID: 31427012]
[http://dx.doi.org/10.1007/s11095-020-02885-x] [PMID: 32761250]
[http://dx.doi.org/10.1371/journal.pone.0047045] [PMID: 23077543]
[http://dx.doi.org/10.1200/JCO.2008.19.9919] [PMID: 19528371]
[http://dx.doi.org/10.1096/fj.201700629R] [PMID: 29066614]
[http://dx.doi.org/10.1164/rccm.201508-1545CI] [PMID: 26583808]
[http://dx.doi.org/10.3390/cancers13194854] [PMID: 34638338]
[http://dx.doi.org/10.1016/j.prp.2021.153697] [PMID: 34839096]
[http://dx.doi.org/10.3389/fimmu.2014.00614] [PMID: 25506346]
[http://dx.doi.org/10.1016/j.intimp.2018.10.033] [PMID: 30380514]
[http://dx.doi.org/10.1016/j.biomaterials.2014.03.004] [PMID: 24674464]
[http://dx.doi.org/10.1038/gt.2009.148] [PMID: 19907498]
[http://dx.doi.org/10.1038/nrg1066] [PMID: 12728277]
[http://dx.doi.org/10.1038/nrg3763] [PMID: 25022906]
[http://dx.doi.org/10.1016/j.actbio.2022.09.065] [PMID: 36191773]
[http://dx.doi.org/10.2174/1875533XMTA0cNDEhy] [PMID: 32048951]
[PMID: 23637531]
[http://dx.doi.org/10.1186/1556-276X-6-447] [PMID: 21749688]
[http://dx.doi.org/10.1016/j.clim.2022.109180] [PMID: 36396013]
[http://dx.doi.org/10.1016/j.actbio.2021.11.037] [PMID: 34852301]
[http://dx.doi.org/10.1039/D2TB00571A] [PMID: 35775500]
[http://dx.doi.org/10.1016/j.jconrel.2006.04.014] [PMID: 16831482]
[http://dx.doi.org/10.1039/D2TB00695B] [PMID: 35587692]
[http://dx.doi.org/10.1016/j.actbio.2022.06.030] [PMID: 35738388]
[http://dx.doi.org/10.3390/molecules25184243] [PMID: 32947799]
[http://dx.doi.org/10.2147/IJN.S258906] [PMID: 32922011]
[http://dx.doi.org/10.2147/IJN.S128802] [PMID: 28496326]
[http://dx.doi.org/10.1136/jitc-2021-003973] [PMID: 34969774]
[http://dx.doi.org/10.1016/j.ccr.2014.03.021] [PMID: 24823638]
[http://dx.doi.org/10.1016/j.tranon.2020.100845] [PMID: 32781367]
[http://dx.doi.org/10.7150/jca.46429] [PMID: 33193893]
![Wayfinder Image](/images/wayfinder.jpg)